Social Media Influencers Fueling Unofficial Trade for Unlicensed Slimming Drug
A shadow market for unapproved slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.
Investigational Treatment Acquiring Popularity Online
The experimental drug, which is still in clinical trials, is being advertised by online personalities for its alleged fat-burning properties. Followers are encouraged to contact these profiles privately for supplier links, while also receiving discount codes.
Active Trade on Messaging Platforms
Separately, a flourishing market exists on Telegram, where communities with numerous of members share “before and after” images, injection guides and claims of next-day British shipping. Sellers market the drug there before directing customers to other platforms for purchases.
Learning About Retatrutide
Retatrutide is an investigational injectable created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials suggest it could assist individuals lose up to 25% of their body weight. Referred to as the “triple G”, the substance is being hailed digitally as the next Ozempic.
Medical Professionals Voice Concerns
However, physicians and pharmacists have warned that the sale of what is still an unapproved medication in the UK is worrisome and could lead to individuals injecting products of uncertain source.
Several professionals stated the popularity for the experimental drug could be connected to the increasing cost of licensed slimming products such as Mounjaro.
Regulatory Status and Enforcement
Selling the unapproved drug on social media or Telegram is illegal in the UK, as it is an unapproved medication that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.
Several influencers try to sidestep the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still violate medicines, marketing, and consumer laws, risking penalties, legal action or prison.
Platform Reaction and Material Elimination
Based on TikTok, the service has taken down violative content and prohibited related keywords and search suggestions. The company said it was committed to maintaining the service secure and investing in strengthening compliance measures.
Digital Trading Operations
Research also discovered communities with up to nine thousand members selling retatrutide using Telegram's built-in discovery tool, which operates like a online catalog. Entering “retatrutide” instantly displays channels with thousands of members, populated with images of slimming results, positive reviews and detailed guides for preparing or injecting at home.
After moments of entering one group, a vendor shared WhatsApp details, where the majority of transactions take place. The seller sent an instruction manual and promised shipping within two days. When asked whether the product was genuine, one seller said: “You can’t be sure.” Another provided a image of a alleged testing documentation. Not one inquired about body mass, health issues or previous experience.
Product Information and Costs
Inside these communities, messages show black plastic packages with postal service stickers, claiming to include fresh supplies. One communication read: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, mixed at residence with purified liquid, or ready-to-use injectors usually priced at 160 pounds for 20mg. When asked how long a pen should be used, vendors give conflicting answers varying between a few weeks to “depends on your body”.
Platform Moderation and Safety Actions
A representative for Telegram said it actively moderated dangerous content on its platform including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“Individuals are administering substances they cannot confirm. Even if the science behind retatrutide is sound, these digital products may not include what they claim,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to recent price rises for authorized slimming medications such as Mounjaro. “With prices increasing, patients are turning to online platforms. But fake treatments are highly risky. You cannot know what’s inside or whether the environment they were produced in was clean,” she explained.
Her staff has previously encountered patients injured by self-injection from unconfirmed sources. “We recognize the disappointment, but buying from Telegram or WhatsApp is taking chances with your well-being,” said the doctor. “These materials could be impure or incorrectly dosed.”
Manufacturer Position
A representative from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Therefore at this point no one can market [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a Lilly investigational substance not yet approved … may expose patients to possibly serious health risks”.
